| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Executive Officer
1 company
Lee Kevin is a Chief Executive Officer at BICYCLE THERAPEUTICS PLC. Recent SEC Form 4 filings include 0 buys and 33 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2021 | BCYC Bicycle Therapeutics Plc | Chief Executive Officer | Sale+OE | 55,362 | $33.30 | $1,843,435.94 | -2.6% | +61.2% | -38.4% | |
| May 7, 2021 | BCYC Bicycle Therapeutics Plc | Chief Executive Officer | Sale+OE | 7,320 | $32.21 | $235,769.16 | -1.4% | -5.9% | -35.6% | |
| May 4, 2021 | BCYC Bicycle Therapeutics Plc | Chief Executive Officer | Sale+OE | 4,288 | $32.13 | $137,785.47 | -0.8% | -1.5% | -27.0% | |
| Apr 30, 2021 | BCYC Bicycle Therapeutics Plc | Chief Executive Officer | Sale+OE | 58,919 | $30.86 | $1,817,987.66 | -2.7% | +0.6% | -24.3% | |
| Apr 27, 2021 | BCYC Bicycle Therapeutics Plc | Chief Executive Officer | Sale+OE | 25,247 | $31.13 | $785,872.71 | -2.4% | +13.1% | -19.3% | |
| Feb 5, 2021 | BCYC Bicycle Therapeutics Plc | Chief Executive Officer | Sell | 100 | $31.00 | $3,100.00 | - | - | - | |
| Jan 20, 2021 | BCYC Bicycle Therapeutics Plc | Chief Executive Officer | Sell | 6,185 | $29.76 | $184,069.60 | -0.4% | - | - | |
| Jan 15, 2021 | BCYC Bicycle Therapeutics Plc | Chief Executive Officer | Sell | 10,000 | $26.01 | $260,050.00 | -1.8% | - | - |